Figure 3From: Activity of crizotinib over choroidal metastases in Non-Small-Cell Lung Cancer (NSCLC)-ALK rearranged: a case report Fluorangiography of the left eye, after 6Â months in crizotinib and 2Â months after phacoemulsification with lens implant. Back to article page